Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 9, 2013 - Issue 5
Submit an article Journal homepage
312
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluations

The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease

Tamás TábiSemmelweis University, Department of Pharmacodynamics, Nagyvárad tér 4., Budapest, 1089, Hungary
, PhD (Assistant Professor) ,
Éva SzökőSemmelweis University, Department of Pharmacodynamics, Nagyvárad tér 4., Budapest, 1089, Hungary
, PhD DSc (Full Professor) ,
László VécseiUniversity of Szeged and Neuroscience Research Group of the Hungarian Academy of Sciences and University of Szeged, Albert Szent-Györgyi Clinical Center, Semmelweis utca 6., Szeged, 6725, Hungary+36 62 545351; +36 62 545597; [email protected]
, MD PhD DSc (Member of the Hungarian Academy of Sciences, Full Professor, Head of the Department of Neurology) &
Kálmán MagyarSemmelweis University, Department of Pharmacodynamics, Nagyvárad tér 4., Budapest, 1089, Hungary
, MD PhD DSc (Member of the Hungarian Academy of Sciences, Full Professor)
Pages 629-636 | Published online: 19 Mar 2013

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Peter Riederer & Thomas Müller. (2017) Use of monoamine oxidase inhibitors in chronic neurodegeneration. Expert Opinion on Drug Metabolism & Toxicology 13:2, pages 233-240.
Read now
Hemlata G. Patil, Roshan V. Tiwari, Michael A. Repka & Kamalinder K. Singh. (2016) Formulation and development of orodispersible sustained release tablet of domperidone. Drug Development and Industrial Pharmacy 42:6, pages 906-915.
Read now
Livia Dézsi & László Vécsei. (2014) Safinamide for the treatment of Parkinson's disease. Expert Opinion on Investigational Drugs 23:5, pages 729-742.
Read now
Livia Dézsi & László Vécsei. (2014) Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs. Expert Opinion on Drug Metabolism & Toxicology 10:3, pages 409-424.
Read now

Articles from other publishers (7)

Barry R. Bryant, Heidy Vanessa Rivera-Muniz, Tae Joon Park, Sujin Weinstein & Paul S. Nestadt. (2021) Knowledge surrounding proper administration of antipsychotic orally disintegrating tablets. General Hospital Psychiatry 68, pages 107-108.
Crossref
Della G.T. Parambi. (2020) Treatment of Parkinson’s Disease by MAO-B Inhibitors, New Therapies and Future Challenges - A Mini-Review. Combinatorial Chemistry & High Throughput Screening 23:9, pages 847-861.
Crossref
Andrew Schneider, Adam T. Sari, Hasan Alhaddad & Youssef Sari. (2020) Overview of Therapeutic Drugs and Methods for the Treatment of Parkinson’s Disease. CNS & Neurological Disorders - Drug Targets 19:3, pages 195-206.
Crossref
Tamás Tábi, László Vécsei, Moussa B. Youdim, Peter Riederer & Éva Szökő. (2019) Selegiline: a molecule with innovative potential. Journal of Neural Transmission 127:5, pages 831-842.
Crossref
Ling Yang, Chi-Lin Li & Tung-Hu Tsai. (2020) Preclinical Herb–Drug Pharmacokinetic Interaction of Panax ginseng Extract and Selegiline in Freely Moving Rats . ACS Omega 5:9, pages 4682-4688.
Crossref
Corey Tapper, Robert Arnold & Jennifer Pruskowski. (2019) Non-Oral Pharmacotherapy Options for Depression #372. Journal of Palliative Medicine 22:4, pages 454-455.
Crossref
Zhen Yang, Sutthilug Sotthivirat, Yunhui Wu, Anita Lalloo, Becky Nissley, Kimberly Manser & Hankun Li. (2016) Application of in vitro transmucosal permeability, dose number, and maximum absorbable dose for biopharmaceutics assessment during early drug development for intraoral delivery. International Journal of Pharmaceutics 503:1-2, pages 78-89.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.